Targeting catecholate siderophore systems enables precision depletion of gut enterobacteria during colitis
These findings establish catecholate siderophore-mediated iron acquisition as a therapeutic target in AIEC and provide proof-of-principle that virulence-targeted immunization can selectively antagonize a disease-associated bacterium while preserving the gut microbiota.